Tania Benjamin

Tania Benjamin

Auto-generated profile, based on publicly available information

Tania Benjamin

Department of Otolaryngology–Head and Neck Surgery University of California San Francisco USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in American Journal of Audiology
Verified
Journal Article
Closed access
TBTania Benjamin
Tania Benjamin
AGAdam Gardi
Adam Gardi
JSJeffrey D. Sharon
Jeffrey D. Sharon
Purpose: The aim of this study was to review current literature regarding the epidemiology of vestibular migraine (VM), patient presentation, pathogenesis, and treatment. Recent Findings: VM is becoming an increasingly recognized condition in the United States, currently affecting 2.7% of people. Patients may experience vestibular symptoms, such as vertigo and imbalance, with or without other migrainous symptoms. Recent evidence has also shown that patients with VM are at higher risk for cochlear dysfunction, such as sudden deafness, sensorineural hearing loss, and tinnitus. The heritability and genetics are not well understood, and the pathogenesis may involve calcitonin gene-related peptide, which is also implicated in migraine headaches. A disease-specific patient reported outcome measure, the Vestibular Migraine Patient Assessment Tool and Handicap Inventory, was recently developed and validated. A limited number of controlled trials have assessed various therapies for VM, including triptans and beta-blockers. More data are needed to understand whether or not currently available migraine treatments are effective for VM. Summary: VM is a common etiology of vertigo and dizziness, presenting with a characteristic spectrum of symptoms. Early data suggest that migraine treatments may be helpful in some cases.

5 July 2023 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
TBTania Benjamin
Tania Benjamin
AGArushi Gulati
Arushi Gulati
AZAaron L. Zebolsky
Aaron L. Zebolsky
RSRahul Seth
Rahul Seth
DKDaniel Knott
Daniel Knott
APAndrea M. Park
Andrea M. Park
Background: Research has not explicitly explored differences between male and female microvascular head and neck (MHN) surgeon burnout, which should be identified and addressed to ensure career satisfaction and longevity. Objective: To measure and compare the prevalence of burnout among male versus female MHN surgeons. Methods: A prospective questionnaire based on the Maslach Burnout Inventory (MBI) was distributed through a web-based survey to the American Association of Facial Plastic and Reconstructive Surgeons and American Head and Neck Society in 2021 and 2022. Additional variables collected included demographics, relationship and parental status, academic rank, annual salary, and COVID-19-related questions. Results: One hundred thirteen surveys were collected. Twenty-nine (25.7%) were women and all completed MHN surgery fellowships. Women trended toward more emotional exhaustion than men (2.8 mean MBI vs. 2.3 mean MBI) but reported similar personal achievement (4.8 mean MBI vs. 4.9 mean MBI). Men experienced less workplace sexual harassment ( p < 0.001). Women experienced more burnout (69% vs. 39%, p = 0.006) during the COVID-19 pandemic. Conclusion: Female MHN surgeons reported in this survey to experience more workplace sexual harassment and higher COVID-19-related burnout than their male counterparts.

3 March 2023 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
TBTania Benjamin
Tania Benjamin
AZAaron L. Zebolsky
Aaron L. Zebolsky
AHAlexander F. Haddad
Alexander F. Haddad
EOEdgar Ochoa
Edgar Ochoa
KPKarolina A. Plonowska-Hirschfeld
Karolina A. Plonowska-Hirschfeld
DKDaniel Knott
Daniel Knott
Background: An anterior thigh split thickness skin graft (AT-STSG) is frequently needed to close the radial forearm free flap (RFFF) donor site, conferring morbidity to two extremities. The anterolateral thigh (ALT) free flap is virtually always closed primarily. Objective: To compare donor site pain, sensation, motor function, and cosmesis associated with the AT-STSG and the ALT. Methods: Patients undergoing an ALT or an RFFF with AT-STSG were enrolled in a prospective observational cohort study. Pain, tingling, numbness, lower extremity function, and subjective donor site cosmetic satisfaction were measured at 1 week and 1 month postoperation using validated instruments. Results: Forty-eight patients were included, with a mean age of 64.2 years (female 31.2%). There were no differences in age or medical comorbidities between the two groups. The average donor defect was 50 and 180 cm 2 for the AT-STSG and ALT cohorts, respectively. At 1 week and 1 month postoperatively, we did not detect a difference in donor site pain, pruritus, numbness or tingling, lower extremity function, or subjective cosmetic satisfaction between the two cohorts. Conclusion: ALT primary donor site morbidity, including pain, sensory function, motor function, and cosmesis, is equivalent to RFFF secondary donor site morbidity at 1 week and 1 month postoperatively.

6 October 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
Tiffany HusmanTiffany Husman
Tiffany Husman
TBTania Benjamin
Tania Benjamin
MDMegan L. Durr
Megan L. Durr
JCJolie L. Chang
Jolie L. Chang

29 July 2022 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
TBTania Benjamin
Tania Benjamin
ADAbel P. David
Abel P. David
AZAaron L. Zebolsky
Aaron L. Zebolsky
ESElizabeth A. Shuman
Elizabeth A. Shuman
APAndrea M. Park
Andrea M. Park
RSRahul Seth
Rahul Seth
Background: Anterolateral thigh (ALT) microvascular free tissue transfer is an integral part of head and neck reconstructive surgery, but it can be complicated by postoperative donor site fluid collections. Objective: To measure the rate of hematoma and seroma formation in the ALT donor site in those treated with microporous polysaccharide hemosphere (MPH) and those without. Methods: This was a retrospective cohort study examining patients undergoing ALT free tissue transfer for head and neck reconstruction at a single academic center between 2014 and 2017. Primary outcomes were interventional hematomas and seromas and drain duration. Results: In total, 118 patients underwent ALT free flap reconstruction for head and neck defects. Of these, 57 patients received MPH at the donor site and 61 did not. Eleven patients had a clinically significant seroma in the non-MPH group compared with three in the MPH group ( p = 0.045). Drain duration for the MPH group compared with that for the non-MPH group was 6.9 versus 8.2 days ( p = 0.020), and drains were removed when output was <60 mL over 24 h. Conclusion: This study supports the use of MPH in ALT free flap donor sites for reduction of clinically significant postoperative seromas. Further investigation with larger prospective randomized clinical trials is warranted.

1 July 2024 in Facial Plastic Surgery & Aesthetic Medicine
Verified
Journal Article
Closed access
TBTania Benjamin
Tania Benjamin
GSGaelen Stanford-Moore
Gaelen Stanford-Moore
STSonia Targ
Sonia Targ
NHNancy K. Hills
Nancy K. Hills
APAndrea M. Park
Andrea M. Park
RSRahul Seth
Rahul Seth
Facial Plastic Surgery & Aesthetic Medicine